Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Research progress on the prevention and treatment of exercise-induced fatigue with ginseng and relevant formulas.

Frontiers in pharmacology·2026
Same author

VIF-Ig: a novel fc framework for ADCC by incorporation of VHH unit.

Protein engineering, design & selection : PEDS·2026
Same author

Genome-wide transcriptomic analysis reveals autophagy and HSP70-mediated mechanisms underlying thermal stress adaptation in Mytilus coruscus.

BMC genomics·2025
Same author

SUMOylation of AL6 regulates seed dormancy and thermoinhibition in Arabidopsis.

The New phytologist·2024
Same author

Hydrogen combined with tetrandrine attenuates silica-induced pulmonary fibrosis via suppressing NF-kappaB/NLRP3 signaling pathway-mediated epithelial mesenchymal transition and inflammation.

International immunopharmacology·2024
Same author

BMSCs-laden mechanically reinforced bioactive sodium alginate composite hydrogel microspheres for minimally invasive bone repair.

Carbohydrate polymers·2024

Related Experiment Video

Updated: Jun 21, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Palliative procedures for congenital heart defects.

Shi-Min Yuan1, Hua Jing

  • 1Department of Cardiothoracic Surgery, Jinling Hospital, School of Clinical Medicine, Nanjing University, Nanjing, Jiangsu Province 210002, People's Republic of China.

Archives of Cardiovascular Diseases
|August 12, 2009
PubMed
Summary

Palliative procedures are crucial for congenital heart defects when total repair isn't possible. This review clarifies 21 procedures, aiding surgeons and cardiologists in managing complex pediatric heart conditions.

Related Experiment Videos

Last Updated: Jun 21, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Surgery
  • Cardiovascular Interventions

Background:

  • Palliative procedures remain vital for congenital heart defects (CHDs), especially in emergent situations or when complete correction is not feasible.
  • Existing classifications and concepts of palliative CHD procedures can be ambiguous for clinicians.
  • A comprehensive overview is needed to clarify these procedures for better understanding and application.

Purpose of the Study:

  • To provide a full-scope review of palliative procedures for congenital heart defects.
  • To clarify the concepts, categories, indications, historical development, and clinical outcomes of these procedures.
  • To aid young cardiac surgeons and cardiologists in understanding and applying palliative techniques.

Main Methods:

  • Literature review of documented palliative procedures for congenital heart defects.
  • Classification of 21 identified palliative procedures into four main categories.
  • Analysis of historical developments, indications, and clinical outcomes.

Main Results:

  • Identified 21 palliative procedures for CHDs, categorized into four groups: increasing pulmonary artery flow, decreasing pulmonary artery flow, enhancing intracardiac blood-oxygen mixture, and other specific conditions.
  • Highlighted Modified Blalock-Taussig's shunt, Glenn's shunt, and pulmonary artery banding as pre-eminent and long-term satisfactory procedures.
  • Observed a growing trend towards interventional techniques with stent deployment as an alternative to surgical palliation.

Conclusions:

  • Palliative procedures are essential in managing CHDs, offering symptom relief when definitive repair is not an option.
  • A clear taxonomy of palliative procedures improves clinical decision-making for congenital heart disease management.
  • Interventional cardiology approaches are emerging as viable alternatives for palliative care in CHDs.